Enabling Rapid and High-Precision Digital Drug Design

Celebrating a industry-university research collaboration made possible through the Commonwealth Department of Education’s National Industry PhD Program: Associate Professor Giuseppe Barca from The Australian National University and QDX Technologies Pty Ltd’s Founder Loong Wang will work with three PhD candidates to create software using high-fidelity quantum molecular modelling to enable computational-driven virtual screening and accurate drug design. The project will create a next-generation digital platform for quicker and more cost-effective drug design that will lead to faster and lower-cost drug development, benefiting both everyday patients and the businesses producing these drugs.